Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,127 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Prevalence and risk factors of bone fragility in duchenne muscular dystrophy: A systematic review and meta-analysis.
Liu C, Yang D, Xu T, Fu H, Zhou L, Cai X, Guo Y, Xu H. · Osteoporos Int · 2026 · cited 1 timesmeta-analysis, systematic review
- Safety and efficacy of delpacibart zotadirsen in Duchenne muscular dystrophy mutations amenable to exon 44 skipping in the USA (EXPLORE44): a randomised, placebo-controlled, double-blind, phase 1/2 trial.
Veerapandiyan A, Eskuri J, Laverty CG, McDonald CM, Phan H, Smith EC, Tesi Rocha C, Wong B, Morris M, Tami Y, Carmack T, Kovach P, Herzog JJ, Hughes SG, Zhu Y, Ackermann EJ, Flanigan KM, EXPLORE44 Study Investigators. · Lancet Neurol · 2026 · cited 1 timesclinical trial, phase ii, multicenter study
- Improving survival in Duchenne muscular dystrophy across eras: a systematic review and cumulative meta-analysis.
Benning L, Bousraou Z, Gruber B, Ulrich S, Schwarz EI. · J Neurol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Effects of Virtual Reality Versus Whole-Body Vibration on Muscle Strength and Balance in Children with Duchenne Muscular Dystrophy: a Randomized Controlled Trial.
Ali MS, Usama M. · NeuroRehabilitation · 2026 · cited 0 timesrandomized controlled trial
- Accuracy of the molecular diagnosis of duchenne and becker muscular dystrophy: A systematic review with meta-analysis.
Chavez-Ecos FA, Quispe-Vicuña C, Malaga M, Pacheco-Barrios N, Huerta-Rosario A, Velasquez-Rimachi V, Martinez Esteban P, Alva-Diaz C. · PLoS One · 2026 · cited 1 timesOpen accessmeta-analysis, systematic review
- Incidence, Timing and Clinical Significance of Immune-Mediated Myocardial Injury and Myocarditis After Gene Replacement Therapy: A Systematic Review and Meta-Analysis.
Maurizi N, Ammirati E, Silver E, Hong K, Bui Q, Argirò A, Olivotto I, Adler ED. · Circ Heart Fail · 2026 · cited 1 timesmeta-analysis, systematic review
- Effectiveness of telerehabilitation on motor and respiratory function in duchenne muscular dystrophy: a systematic review and meta-analysis.
Vinolo-Gil MJ, Muñoz-Pérez L, Dominguez-Vera PA, García-Campanario I, Estebánez-Pérez MJ, Martín-Valero R. · Disabil Rehabil · 2026 · cited 0 timesmeta-analysis, systematic review
- Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised, placebo-controlled study.
Muntoni F, Nascimento A, Shin J, Guglieri M, Stettner GM, Veerapandiyan A, Gallo S, Shi H, Gundapaneni B, Neelakantan S, Lobello K, Shen Q, Levy DI, Mercuri E, CIFFREO Study Group. · Lancet Neurol · 2026 · cited 7 timesclinical trial, phase iii, multicenter study
- Safety and Efficacy of Tamoxifen in Patients with Duchenne muscular dystrophy: open Label Extension of TAMDMD Trial.
Zwingli G, Putananickal N, Schmidt S, Nagy S, Rubino-Nacht D, Schaedelin S, Amthor H, Childs AM, Deconinck N, Horrocks I, Houwen-van Opstal S, Laugel V, Lopez Lobato M, Nascimento Osorio A, Schara-Schmidt U, Spinty S, von Moers A, Lawrence F, Hafner P, Dorchies OM, Fischer D, Henzi BC. · Neuromuscul Disord · 2026 · cited 0 timesclinical trial, phase iii, multicenter study
- Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.
Clemens PR, Berglund A, Schiava M, James MK, McDermott MP, Bushby K, Lampa E, Rochford ETJ, Ward LM, Griggs RC, Hoffman EP, Guglieri M. · Neurology · 2026 · cited 0 timesOpen accessclinical trial, phase ii, comparative study
- Transition to adulthood in Duchenne Muscular Dystrophy: a systematic review with narrative synthesis on health systems, policies, and the role of health care providers.
Friedrich S, Willems J, Rodger S, Petropoulos JA, Ringer D, Wang E, Frei J, Pozniak K, Swain A, Guastafierro E, Marcassoli A, Trucco G, Mazzilli A, Reeskau G, De Angelis F, Osman H, Fournier A, Gutierrez Rojas RG, Gorter JW, Moroni I, Leonardi M, Nardocci N, Kraus de Camargo O, Langer T. · Front Public Health · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.
McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan HC, Apkon S, Ghosh PS, Tian C, Veerapandiyan A, Ramos-Platt L, Gambetta K, Bernes SM, Varadhachary AS, Iannaccone ST, Laverty CG, Perlman SJ, Bass NE, Mosher K, Butterfield RJ, Mathews KD, Scharf RJ, Smith EC, Emerson JA, Mercuri E, Awadalla MS, Marbán L, Marbán E, HOPE-3 Investigators. · Lancet · 2026 · cited 0 timesclinical trial, phase iii, research support, non-u.s. gov't
- Functional electrical stimulation for major depressive disorder: Protocol for a pilot randomized controlled trial.
Gholamali Nezhad F, Yu H, Demchenko I, Iwasa SN, DiNunzio S, Ghosh R, Zariffa J, Masani K, Lou W, Mulsant BH, Naguib HE, Popovic MR, Bhat V. · PLoS One · 2026 · cited 0 timesOpen accessclinical trial protocol
- Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy.
Ompad G, Saura PM, Heckmann NS, Rossi A, Olmastroni E, Casula M, Sessa M. · BMC Pharmacol Toxicol · 2026 · cited 0 timesOpen accessmeta-analysis
- Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.
Degan C, Tobin RA, de Vries SI, Jiménez-Requena A, Peco A, Guglieri M, Diaz-Manera J, van der Burgt YEM, van Vlijmen BJM, FOR-DMD investigators of the Muscle Study Group, Hathout Y, Szigyarto CA, Dang UJ, Tsonaka R, Spitali P. · Skelet Muscle · 2026 · cited 1 timesOpen accessrandomized controlled trial
- A pre-post single-arm pilot trial of a digital multicomponent intervention for self-efficacy enhancement among online support groups of primary caregivers of children with neuro-muscular disorders: SEE-NMD protocol.
Aziz NI, Khalid W, Khan S. · PLoS One · 2026 · cited 0 timesOpen accessclinical trial protocol
- Efficacy of delandistrogene moxeparvovec on Duchenne muscular dystrophy: a systematic review and meta-analysis.
Pascual-Morena C, Patiño-Cardona S, Martínez-García I, Fernández-Bravo-Rodrigo J, Garrido-Miguel M. · Hum Genet · 2025 · cited 11 timesmeta-analysis, systematic review
- Five-Year Outcomes With Delandistrogene Moxeparvovec in Patients With Duchenne Muscular Dystrophy: A Phase 1/2a Study.
Mendell JR, Sahenk Z, Lowes LP, Iammarino MA, Alfano LN, McDonald CM, Signorovitch JE, Jin J, Li J, Mason S, Rodino-Klapac LR. · Muscle Nerve · 2026 · cited 1 timesOpen accessclinical trial, phase ii, clinical trial, phase i
- ALG-020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug-Induced Liver Injury.
Agarwal K, Forton D, Zen Y, Wu M, Lin TI, Le K, Chanda S, Blatt L, Fry J, Gane E. · J Viral Hepat · 2026 · cited 0 timesclinical trial, phase i, randomized controlled trial
- Lumbopelvic stabilization-based physiotherapy and rehabilitation and urotherapy for lower urinary tract dysfunction in Duchenne Muscular Dystrophy: a randomized controlled trial.
Öztürk D, Ayşe Karaduman A, Akbayrak T. · J Pediatr (Rio J) · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Prevalence of Vitamin D Deficiency in Ataxia-Telangiectasia: A Systematic Review and Single Arm Meta-Analysis.
Iqbal MJ, Azhar M, Javaid H, Hassan A, Masood A, Menotta M. · Cerebellum · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- A systematic review of the frequency of sleep evaluations, sleep disorders, and treatments among individuals with muscular dystrophy.
Whitehead N, Alese JT, Hill C, Enger M, Zimmerman J, Moore A, Royer J, Venkatash S, Thomas S, Do B, Howard JF. · J Clin Sleep Med · 2026 · cited 0 timessystematic review
- Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trials.
de Vera A, Clemens PR, Dang UJ, Dutreix C, Gresko E, Guglieri M, Hagerty L, Hasham S, Damsker J, Hathout Y, Linden A, Berglund A, Tobin R, Wahbi K, Hoffman EP. · Steroids · 2025 · cited 10 timesclinical trial, phase i, randomized controlled trial
- CRISPR Gene Editing for Nucleotide Repeat Expansion Disorders: A Systematic Review of Preclinical and Clinical Evidence.
Thalib HI, Khan S, Hanin Shaikh A, Alawi KM, Alabdrabalrasol ZH, Mehveen S, Haidar S, ElSayed Hassan F, Shaik NA. · Genet Test Mol Biomarkers · 2026 · cited 0 timessystematic review
- Association between the ACTN3 R577X polymorphism and skeletal muscle mass: a systematic review and meta-analysis.
Hattori S, Kamiya-Saito M, Kikuchi N, Nakazato K. · J Physiol Anthropol · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.